medRxiv PreprintsInternational12 November 2026
An observational study examining nasopharyngeal resistome evolution among children under the selective pressure of antibiotic exposure and hospitalisation for pneumonia in Malawi: A study protocol
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Introduction Antimicrobial resistance (AMR) to first line antibiotics for pneumonia is a major global health problem, and AMR-attributable deaths are prevalent in sub-Saharan Africa. Improved data on how AMR develops and influences health outcomes in resource limited settings is crucial. The nasopharynx is a reservoir for pneumonia pathogens and their resistome, the genetic determinants of AMR. No study has explored whether human resistome composition in children with pneumonia is associated with health outcomes. This study will examine whether antibiotic treatment and hospital admission for p
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Silent Drift and Site-level Variance in Clinical AI: Real-world performance and subgroup analysis for post-market monitoring of an FDA-cleared artificial intelligence (AI) triage tool for high-risk use case of pulmonary embolism12 November 2026
- Determinants of mpox vaccine acceptance among peri-urban residents in Sekondi-Takoradi, Western Region of Ghana: A community-based cross-sectional study12 November 2026
- Mapping disordered eating symptoms in the ABCD Study through the Eating Disorder Symptom Index12 November 2026
- Influenza Vaccination and Disease Severity Among Older Adults Hospitalized with Influenza in France: A Nationwide Cohort Study, 2016-202412 November 2026
- Associations of drinking water per- and polyfluoroalkyl substances with cause-specific mortality in men with prostate cancer12 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.